Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
Caroline A. Lee(Pfizer (United States)), John S. Grundy(Pfizer (United States)), Stefan Schreiber(Christian-Albrechts-Universität zu Kiel), Brian Bressler(University of British Columbia), Yong Tang(Pfizer (United States)), Jinkun Zhang(Pfizer (United States)), D. Alexander Oh(Pfizer (United States)), Heather Kiyomi Komori(Pfizer (United States)), John Adams
Cited by 17
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k
Certolizumab Pegol for the Treatment of Crohn's Disease
|New England Journal of Medicine|2007|1.1k